The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference46 articles.
1. Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013;Read;Diabetologia,2016
2. Epidemiology and management of hyperlipidemia;Karr;Am J Manag Care,2017
3. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045;Cho;Diabetes Res Clin Pract,2018
4. Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes;Fan;Lipids Health Dis,2018
5. Comparison of twelve single-drug regimens for the treatment of type 2 diabetes mellitus;Wang;Oncotarget,2017
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells;Microvascular Research;2024-05
2. Silybin A fromSilybum marianumreprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids;2024-04-11
3. Impacts of Supplementation with Silymarin on Cardiovascular Risk Factors: A Systematic Review and Dose–Response Meta-Analysis;Antioxidants;2024-03-24
4. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose–response meta‐analysis;Phytotherapy Research;2024-03-12
5. Cost-effectiveness of dietary supplement ingredients versus generic statins for LDL reduction;Exploratory Research in Clinical and Social Pharmacy;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3